NCT06186141View on ClinicalTrials.gov

Nausea and Vomiting in Postoperative Paediatric Patients With Patient-Controlled Analgesia (PCA): Morphine vs Oxycodone

PHASE4RecruitingINTERVENTIONAL
Enrollment

690

Participants

Timeline

Start Date

March 13, 2024

Primary Completion Date

March 19, 2026

Study Completion Date

March 19, 2027

Conditions
Patient-Controlled Analgesia
Interventions
DRUG

Morphine

Intravenous (IV) delivery via Patient Controlled Analgesia device (PCA) 20mcg/kg bolus to a maximum of 1mg with a 5-minute lockout

DRUG

Oxycodone

Intravenous (IV) delivery via Patient Controlled Analgesia device (PCA) 20mcg/kg bolus to a maximum of 1mg with a 5-minute lockout

Trial Locations (1)

3052

RECRUITING

The Royal Children's Hospital, Melbourne

Sponsors
All Listed Sponsors
lead

Murdoch Childrens Research Institute

OTHER

NCT06186141 - Nausea and Vomiting in Postoperative Paediatric Patients With Patient-Controlled Analgesia (PCA): Morphine vs Oxycodone | Biotech Hunter | Biotech Hunter